Evidence map›Paper›PMID 41131118›Full record

ArticleScientific reports2025

A new in vitro pre-clinical method for testing SARS-CoV-2 nasopharyngeal swabs.

Ian Camilo Orjuela-Garzón, Inés María Fernández-Calderón, María de Los Ángeles Ayala, María Alejandra Rodríguez Soto, Camilo Eduardo Pérez-Cualtán, Camila Irene Castro-Paez, Juan C Cruz, Carolina Muñoz-Camargo, Javier Navarro, Rodrigo Cabrera and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ian Camilo Orjuela-GarzónDepartment of Biomedical Engineering, Universidad de los Andes, Cra. 1 Este N° 19A 40, Bogotá, 1117111, DC, Colombia. ic.orjuela@uniandes.edu.co.
Inés María Fernández-CalderónDepartment of Biomedical Engineering, Universidad de los Andes, Cra. 1 Este N° 19A 40, Bogotá, 1117111, DC, Colombia.
María de Los Ángeles AyalaDepartment of Biomedical Engineering, Universidad de los Andes, Cra. 1 Este N° 19A 40, Bogotá, 1117111, DC, Colombia.
María Alejandra Rodríguez SotoDepartment of Biomedical Engineering, Universidad de los Andes, Cra. 1 Este N° 19A 40, Bogotá, 1117111, DC, Colombia.
Camilo Eduardo Pérez-CualtánDepartment of Biomedical Engineering, Universidad de los Andes, Cra. 1 Este N° 19A 40, Bogotá, 1117111, DC, Colombia.
Camila Irene Castro-PaezDepartment of Biomedical Engineering, Universidad de los Andes, Cra. 1 Este N° 19A 40, Bogotá, 1117111, DC, Colombia.
Juan C CruzDepartment of Biomedical Engineering, Universidad de los Andes, Cra. 1 Este N° 19A 40, Bogotá, 1117111, DC, Colombia.
Carolina Muñoz-CamargoDepartment of Biomedical Engineering, Universidad de los Andes, Cra. 1 Este N° 19A 40, Bogotá, 1117111, DC, Colombia.
Javier NavarroCenter for Modeling and 3D Printing, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia.
Rodrigo CabreraCenter for Research in Genetics and Genomics (CIGGUR), GENIUROS Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
Juan C BriceñoDepartment of Biomedical Engineering, Universidad de los Andes, Cra. 1 Este N° 19A 40, Bogotá, 1117111, DC, Colombia.

Funding

Ministerio de Ciencia, Tecnología e Innovación contract 744-2021 (Project code #223989785090)
6 · The paper itself

Abstract

The SARS-CoV-2 pandemic underscored the critical role of nasopharyngeal swabbing in virus detection and containment. The urgency for mass production of swabs highlighted the necessity to evaluate their efficiency against the global shortage of medical supplies. Traditional pre-clinical swab testing methods often overlook the complexities of the nasopharyngeal anatomy and mucus properties. This study introduces an innovative in vitro pre-clinical model using a 3D-printed nasopharyngeal cavity lined with a mucus-mimicking SISMA hydrogel, to generate a novel assessment protocol for nasopharyngeal swab efficiency. Reconstructing nasopharyngeal anatomy from CT images, the model used flexible and rigid resins to simulate soft tissue and bone properties. Our evaluation compared the sample collection and release performance of experimental Heicon-type injection-molded swabs and conventional nylon flocked swabs. The Heicon swabs exhibited superior SISMA release efficiency, compared to the standard tubular model. Both swab types demonstrated lower cycle threshold (Ct) values in the tubular model, indicative of higher viral load retrievals. RT-qPCR results confirmed these differences and validated the hydrogel's suitability as a mucosa equivalent. The findings support using our nasopharyngeal model, which better simulates clinical conditions, potentially improving swab design and the reliability of viral detection assays.

Indexed as

COVID-19COVID-19 TestingNasopharynxSARS-CoV-2Specimen HandlingHumansHydrogelsPrinting, Three-DimensionalViral LoadHydrogelsIn vitro testing, SARS-CoV-2, yellow feverNasopharyngeal swabsPre-clinical model

Identifiers

PMID41131118
PMCPMC12549864

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.